Details

Last Funding Type

Seed

Last Funding Money Raised

Fr2M

Industries

Biotechnology,Health Care

Founded date

Jan 1, 2016

Number Of Employee

11 - 50

Operating Status

Active

GliaPharm is a Swiss-based biotechnology company that offers treatments for neurological and psychiatric disorders.

GliaPharm's innovative therapeutic approach is to target glial cells , the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Their vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.

GliaPharm is a Swiss biotechnology company active in the development of treatments for neurological and psychiatric diseases.

The innovative therapeutic approach of GliaPharm is to target glial cells , or 'support cells' of neurons, to support and improve brain metabolism under certain pathological conditions. Their vision is to become a leader in the development of glial cell targeting agents that act as neuroprotective agents and maintain cognitive functions.